187 related articles for article (PubMed ID: 37017636)
41. An Enhancer-Driven Stem Cell-Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer.
Liang X; Duronio GN; Yang Y; Bala P; Hebbar P; Spisak S; Sahgal P; Singh H; Zhang Y; Xie Y; Cejas P; Long HW; Bass AJ; Sethi NS
Gastroenterology; 2022 Jan; 162(1):209-222. PubMed ID: 34571027
[TBL] [Abstract][Full Text] [Related]
42. Crenolanib Regulates ERK and AKT/mTOR Signaling Pathways in RAS/BRAF-Mutated Colorectal Cancer Cells and Organoids.
Fujino S; Miyoshi N; Ito A; Yasui M; Ohue M; Ogino T; Takahashi H; Uemura M; Matsuda C; Mizushima T; Doki Y; Eguchi H
Mol Cancer Res; 2021 May; 19(5):812-822. PubMed ID: 33579816
[TBL] [Abstract][Full Text] [Related]
43. PDEδ inhibition impedes the proliferation and survival of human colorectal cancer cell lines harboring oncogenic KRas.
Klein CH; Truxius DC; Vogel HA; Harizanova J; Murarka S; Martín-Gago P; Bastiaens PIH
Int J Cancer; 2019 Feb; 144(4):767-776. PubMed ID: 30194764
[TBL] [Abstract][Full Text] [Related]
44. miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.
Ye YP; Wu P; Gu CC; Deng DL; Jiao HL; Li TT; Wang SY; Wang YX; Xiao ZY; Wei WT; Chen YR; Qiu JF; Yang RW; Lin J; Liang L; Liao WT; Ding YQ
Oncotarget; 2016 Sep; 7(38):61312-61324. PubMed ID: 27494869
[TBL] [Abstract][Full Text] [Related]
45. Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis.
He SY; Li YC; Wang Y; Peng HL; Zhou CL; Zhang CM; Chen SL; Yin JF; Lin M
World J Gastroenterol; 2022 Jul; 28(25):2920-2936. PubMed ID: 35978873
[TBL] [Abstract][Full Text] [Related]
46. Oncogenic PIK3CA mutations in colorectal cancers and polyps.
Whitehall VL; Rickman C; Bond CE; Ramsnes I; Greco SA; Umapathy A; McKeone D; Faleiro RJ; Buttenshaw RL; Worthley DL; Nayler S; Zhao ZZ; Montgomery GW; Mallitt KA; Jass JR; Matsubara N; Notohara K; Ishii T; Leggett BA
Int J Cancer; 2012 Aug; 131(4):813-20. PubMed ID: 21932420
[TBL] [Abstract][Full Text] [Related]
47. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
[TBL] [Abstract][Full Text] [Related]
48. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
Kim H; Kim BH; Lee D; Shin E
Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
[TBL] [Abstract][Full Text] [Related]
49. Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells.
Sommer CA; Capilla A; Molina-Estevez FJ; Gianotti-Sommer A; Skvir N; Caballero I; Chowdhury S; Mostoslavsky G
PLoS One; 2018; 13(7):e0200657. PubMed ID: 30024920
[TBL] [Abstract][Full Text] [Related]
50. Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing.
Han SW; Kim HP; Shin JY; Jeong EG; Lee WC; Lee KH; Won JK; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Seo JS; Kim JI; Kim TY
PLoS One; 2013; 8(5):e64271. PubMed ID: 23700467
[TBL] [Abstract][Full Text] [Related]
51. Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations.
Hammond DE; Mageean CJ; Rusilowicz EV; Wickenden JA; Clague MJ; Prior IA
J Proteome Res; 2015 Mar; 14(3):1535-46. PubMed ID: 25599653
[TBL] [Abstract][Full Text] [Related]
52. Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing.
Sayed S; Sidorova OA; Hennig A; Augsburg M; Cortés Vesga CP; Abohawya M; Schmitt LT; Sürün D; Stange DE; Mircetic J; Buchholz F
Cancer Res; 2022 Sep; 82(17):3002-3015. PubMed ID: 35802645
[TBL] [Abstract][Full Text] [Related]
53. EphA3 promotes malignant transformation of colorectal epithelial cells by upregulating oncogenic pathways.
Li M; Yang C; Liu X; Yuan L; Zhang F; Wang M; Miao D; Gu X; Jiang S; Cui B; Tong J; Yu Z
Cancer Lett; 2016 Dec; 383(2):195-203. PubMed ID: 27721017
[TBL] [Abstract][Full Text] [Related]
54. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
55. Prioritizing Gene Cascading Paths to Model Colorectal Cancer Through Engineered Organoids.
Ping Y; Xu C; Xu L; Liao G; Zhou Y; Deng C; Lan Y; Yu F; Shi J; Wang L; Xiao Y; Li X
Front Bioeng Biotechnol; 2020; 8():12. PubMed ID: 32117908
[TBL] [Abstract][Full Text] [Related]
56. Driver Gene Mutations in Stools of Colorectal Carcinoma Patients Detected by Targeted Next-Generation Sequencing.
Armengol G; Sarhadi VK; Ghanbari R; Doghaei-Moghaddam M; Ansari R; Sotoudeh M; Puolakkainen P; Kokkola A; Malekzadeh R; Knuutila S
J Mol Diagn; 2016 Jul; 18(4):471-9. PubMed ID: 27155048
[TBL] [Abstract][Full Text] [Related]
57. Neoplastic progression of human and rat intestinal cell lines after transfer of the ras and polyoma middle T oncogenes.
Chastre E; Empereur S; Di Gioia Y; el Mahdani N; Mareel M; Vleminckx K; Van Roy F; Bex V; Emami S; Spandidos DA
Gastroenterology; 1993 Dec; 105(6):1776-89. PubMed ID: 8253353
[TBL] [Abstract][Full Text] [Related]
58. Clonal evolution and expansion associated with therapy resistance and relapse of colorectal cancer.
S A; Chakraborty A; Patnaik S
Mutat Res Rev Mutat Res; 2022; 790():108445. PubMed ID: 36371022
[TBL] [Abstract][Full Text] [Related]
59. Mathematical model of colorectal cancer initiation.
Paterson C; Clevers H; Bozic I
Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20681-20688. PubMed ID: 32788368
[TBL] [Abstract][Full Text] [Related]
60. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
